niharika times
  • National
  • Rajasthan
  • Sports
  • Cinema
  • Business
  • Recipe
No Result
View All Result
  • National
  • Rajasthan
  • Sports
  • Cinema
  • Business
  • Recipe
No Result
View All Result
niharika times
No Result
View All Result
Home Business

Details on Amanta Healthcare’s 2025 IPO: Pricing and Subscription Insights

by Tina TinaChouhan
September 1, 2025
Details on Amanta Healthcare's 2025 IPO: Pricing and Subscription Insights

The Amanta Healthcare IPO commenced today and will conclude on September 3, 2025. The price range for each share is set between ₹120 and ₹126, with the company aiming to raise ₹126 crore. Shares are expected to be listed on both BSE and NSE, and they are currently trading at a ₹26 premium in the grey market, indicating a potential higher listing price than the IPO price. On the first day of the offering, the IPO was subscribed 1.68 times overall, with retail investors subscribing 2.61 times and institutional investors at 1.73 times. Key dates to note include the allotment on September 4, 2025, when shares will be allocated, and the listing on September 8, 2025, when trading begins.

Experts suggest that while the company shows strength, there are some associated risks for potential investors.

ShareTweetSend

Related Posts

Hindware Launches New Brand Positioning ‘Designed for Sukoon’

SPACES Launches Campaign Highlighting the Comfort of Home

Recent News

  • Hindware Launches New Brand Positioning ‘Designed for Sukoon’
  • Nicole Kidman and Keith Urban End Their 19-Year Marriage
  • Google Introduces Gemini AI for Enhanced Smart Home Experience
  • SPACES Launches Campaign Highlighting the Comfort of Home
  • Samsung Introduces Quick Installation and Demo Service for Holidays
  • About Us
  • Contact Us
  • Cookie Policy
  • Corrections Policy
  • DMCA
  • Privacy & Policy
  • About
Call us: +91 97996 37175

© 2022 Niharika Times. All Rights Reserved

📰

  • National
  • Rajasthan
  • Sports
  • Cinema
  • Business
  • Recipe

© 2022 Niharika Times. All Rights Reserved

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
Exit mobile version